Skip to main content
. 2021 Mar 24;6(5):522–531. doi: 10.1001/jamacardio.2021.0372

Table 3. Change in Scores From Baseline to 12 Months by Change in KCCQ-OS.

Change Worsening of ≥10 points (n = 536) Worsening of 5-9 points (n = 234) No change (n = 714) Improvement of 5-9 points (n = 341) Improvement of ≥10 points (n = 1047)
NYHA class, median (IQR) 0 (0 to 0) 0 (0 to 0) 0 (0 to 0) 0 (0 to 0) 0 (0 to 1)
KCCQ, median (IQR)
CSS −19 (−29 to −10) −7 (−13 to −2) 0 (−4 to 4) 6 (0 to 13) 21 (13 to 33)
PLS −21 (−33 to −8) −8 (−17 to 0) 0 (−8 to 8) 8 (0 to 17) 25 (8 to 40)
SFS −17 (−33 to −6) −6 (−15 to 0) 0 (−8 to 6) 4 (−4 to 13) 19 (8 to 33)
EQ-5D, median (IQR)
VAS −9 (−20 to 2) −3 (−15 to 5) 0 (−8 to 9) 1 (−8 to 11) 6 (−3 to 20)
Index −0.06 (−0.17 to 0.00) −0.02 (−0.13 to 0.01) 0.00 (−0.06 to 0.05) 0.00 (−0.02 to 0.11) 0.05 (−0.01 to 0.15)

Abbreviations: EQ-5D, EuroQoL 5-dimension; IQR, interquartile range; KCCQ-CSS, Kansas City Cardiomyopathy Questionnaire Clinical Summary Score; KCCQ-OS, Kansas City Cardiomyopathy Questionnaire Overall Summary Score; KCCQ-PLS, Kansas City Cardiomyopathy Questionnaire Physical Limitation Score; KCCQ-SFS, Kansas City Cardiomyopathy Questionnaire Symptom Frequency Score; NYHA, New York Heart Association; VAS, visual analog scale.